№ lp_1_2_22662
File format: docx
Character count: 4886
File size: 114 KB
Anaemia is a condition in which there is a lack of haemoglobin in the blood, leading to reduced oxygen transport to the body’s organs and muscles, commonly seen in patients with chronic kidney disease.
Year:
2017
Region / City:
N/A
Topic:
Nephrology, Anaemia, Chronic Kidney Disease
Document Type:
Patient Information
Organization / Institution:
Nephrology Department
Author:
Emma Head
Target Audience:
Patients with Chronic Kidney Disease
Effective Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
United States
Subject:
Clinical Reminders, Nephrology, Chronic Kidney Disease, Medical Template
Document Type:
Installation Guide
Organization:
Department of Veterans Affairs
Author:
Office of Information Technology
Target Audience:
VA Nephrology/Kidney Medicine Physicians
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023/2024
Region / city:
NHS England
Topic:
Healthcare, Quality and Outcomes Framework (QOF)
Document type:
Business rules, Technical specification
Organization / institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES), NHS England
Target audience:
General practitioners, GP system suppliers
Period of validity:
2023–2024
Approval date:
01/04/2023
Amendment date:
01/04/2024
Description:
This document provides the technical business rules and dataset specifications for Chronic Kidney Disease (CKD) under the Quality and Outcomes Framework (QOF) for use by NHS England and General Practice Systems.
Year:
2020
Region / city:
Australia
Theme:
Health, pharmaceutical, clinical treatment
Document type:
Submission for drug listing
Organization / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Vifor Pharma Pty Limited
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing
Approval date:
12 December 2017
Amendment date:
November 2020
Year:
2017
Region / City:
Europe, North America
Topic:
Infectious diseases, Virology
Document Type:
Scientific article
Organization:
European Food Safety Authority (EFSA)
Author:
Various authors (Christiansen et al., 2011; Cunningham et al., 2002; Gagne & LeBlanc, 2017, etc.)
Target Audience:
Researchers, Public health professionals, Fisheries experts
Effective Period:
Ongoing
Approval Date:
2017
Amendment Date:
N/A
Context:
The document provides a detailed scientific overview of the Infectious Salmon Anaemia Virus (ISAV), specifically focusing on the characteristics and impact of HPR-deleted and HPR0 strains.
Year:
2020
Region / City:
United Kingdom
Topic:
Quality Improvement, Healthcare, Surgery
Document Type:
Research Article
Organization / Institution:
Northumbria Healthcare NHS Foundation Trust, University of York
Author:
Ashley Brian Scrimshire, Alison Booth, Caroline Fairhurst, Elizabeth Coleman, Ajay Malviya, Alwyn Kotze, Chris Tiplady, David Tate, Annie Laverty, Gillian Davis, Win Tadd, Belen Corbacho, Prof David J Torgerson, Dr Catriona McDaid, Prof Mike Reed
Target Audience:
Healthcare professionals, Researchers, Policy makers
Period of Action:
May 2018 - November 2019
Approval Date:
15 February 2018
Date of Last Revision:
November 2019
Year:
2012
Region / City:
Mosul
Topic:
Anaemia in pregnancy
Document Type:
Research Study
Institution:
Nineveh Health Directorate, Al-Khansaa Educational Hospital, AL-Batool and AL-Khansaa Teaching Hospitals
Authors:
Ruqayah Youns Hasani, Sedra A Alnuamy, Duaa I Al Ahmed
Target Audience:
Health professionals, researchers, public health officials
Period of Study:
1st January 2012 – 1st July 2012
Date of Approval:
Not specified
Date of Modifications:
Not specified
Ethical Approval:
Yes, obtained from Nineveh Health Directorate and relevant hospitals
Keywords:
Anemia, pregnant women, Mosul, term pregnancy, iron deficiency
Year:
2023
Region / City:
Australia
Topic:
Oncology, Haematology, Pharmaceutical Submission
Document Type:
Submission Request
Organisation:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Amgen Australian Pty Ltd
Target Audience:
Healthcare professionals, Pharmaceutical industry
Period of Validity:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
United Kingdom
Topic:
Health and nutrition
Document type:
Educational questionnaire
Institution:
National Health Service (NHS)
Target audience:
Teenagers
Key terms:
Iron deficiency, anaemia, haem iron, non-haem iron, vitamins
Format:
Multiple-choice and true/false questions
Language:
English
Year:
2026
Region / city:
European Union
Topic:
Personalized Medicine for Cardiovascular, Metabolic, and Kidney Diseases
Document type:
Pre-proposal application form
Organization / Institution:
European Union Funding Agencies
Author:
Not specified
Target audience:
Research institutions, academic institutions, and industry partners
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Contextual description:
A pre-proposal application form for the CARMEN2026 joint transnational call for proposals aimed at personalized medicine for cardiovascular, metabolic, and kidney diseases.
Year:
2023
Region / city:
Australia
Topic:
Chronic hyperkalaemia, kidney disease, sodium zirconium cyclosilicate
Document Type:
Submission to PBAC
Agency / organization:
AstraZeneca Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing, based on PBAC recommendation and PBS listing
Approval date:
1 September 2023
Date of amendments:
Not specified
Year:
2015
Country:
New Zealand
City:
Wellington
Subject:
Chronic kidney disease
Document type:
National consensus statement
Issuing body:
Ministry of Health
Authors:
CKD Core Work Group
Target audience:
Clinicians and managers in funder and provider organisations
Healthcare setting:
Primary care
Publication date:
March 2015
ISBN:
978-0-478-44476-6
License:
Creative Commons Attribution 4.0 International
Focus population:
Adults with chronic kidney disease
Clinical scope:
Identification, classification, and management of CKD
Period covered:
Contemporary clinical practice as of 2015
Canberra Health Services Guideline Apixaban and Rivaroxaban Use in Adults with Severe Kidney Disease
Year:
2021
Region / City:
Canberra, Australia
Topic:
Pharmacology / Kidney Disease
Document Type:
Clinical Guideline
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical staff and pharmacists
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / city:
Canberra
Subject:
Chronic Kidney Disease, Pain Management
Document Type:
Guideline
Organization / Institution:
Canberra Health Services
Author:
Unknown
Target Audience:
CHS medical staff
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
[year]
Region / City:
[region]
Topic:
Anticoagulation, Venous Thromboembolism, Kidney Disease
Document Type:
Clinical Practice Guideline
Institution / Organization:
UK Kidney Association
Author:
Kathrine Parker, Albert Power, Yvonne Bernes, Kate Bramham, Richard Buka, Satarupa Choudhuri, Mark Davies, Maria A Gauci, Lauren Hall, Alan Hancock, John Hartemink, Ed Jenkinson, Nicola Korn, Donna Lewis, Gregory Y.H. Lip, Katy Mills, Anneka Mitchell, Lara Roberts, Huw Rowswell, Hannah Stacey, Katherine Stirling, Jecko Thachil, Jung Tsang, Isaac Tseng
Target Audience:
Healthcare professionals in nephrology, haematology, and related fields
Period of Application:
Ongoing
Approval Date:
[month] [year]
Amendment Date:
[month] [year]
Year:
2023/2024
Region / city:
NHS England
Topic:
Healthcare, Quality and Outcomes Framework (QOF)
Document type:
Business rules, Technical specification
Organization / institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES), NHS England
Target audience:
General practitioners, GP system suppliers
Period of validity:
2023–2024
Approval date:
01/04/2023
Amendment date:
01/04/2024
Description:
This document provides the technical business rules and dataset specifications for Chronic Kidney Disease (CKD) under the Quality and Outcomes Framework (QOF) for use by NHS England and General Practice Systems.
Year:
2021
Country:
Australia
Drug:
Dapagliflozin
Brand name:
Forxiga
Dosage form and strength:
Tablet, 10 mg
Sponsor:
AstraZeneca Pty Ltd
Indication:
Chronic kidney disease
Submission type:
Category 1 submission
Requested listing:
Authority Required (Streamlined), General Schedule
Regulatory bodies:
Pharmaceutical Benefits Advisory Committee; Therapeutic Goods Administration
Target population:
Adults with chronic kidney disease with specified eGFR and UACR ranges
Comparator:
Placebo plus standard of care
Intervention:
Dapagliflozin plus standard of care
Clinical claims:
Superior efficacy and non-inferior safety versus standard of care alone
Related indications:
Type 2 diabetes mellitus; heart failure with reduced ejection fraction
Regulatory status date:
Priority review granted 13 November 2020
Year:
2019
Region / City:
Australia
Topic:
Kidney Disease, Healthcare
Document Type:
Strategic Action Plan
Organization:
Kidney Health Australia
Author:
Professor Carol Pollock, Kidney Health Australia Board
Target Audience:
Healthcare professionals, patients, policymakers
Period of validity:
Ongoing
Approval Date:
2019
Date of amendments:
Not specified
Year:
2019
Region / city:
Australia
Topic:
Kidney Disease, Health Policy
Document Type:
Report
Organization / Institution:
Kidney Health Australia
Author:
Dr. Emma Tinning, Dr. Lisa Murphy, A/Prof Shilpa Jesudason
Target Audience:
Health professionals, policymakers, researchers, and the general public
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023 – current
Region / City:
Hepburn, Victoria
Document Type:
Fellowship Description
Organization:
Elder Leadership Academy
Author:
Max Primmer
Target Audience:
Older Men, Health Professionals, Community Members
Period of Action:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A